Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia.
Ozaki T, Kawamoto T, Iimori Y, Takeshita N, Yamagishi Y, Nakamura H, Kamohara M, Fujita K, Tanahashi M, Tsumaki N.
Ozaki T, et al. Among authors: takeshita n.
Sci Rep. 2020 Dec 1;10(1):20915. doi: 10.1038/s41598-020-77345-y.
Sci Rep. 2020.
PMID: 33262386
Free PMC article.